What is a normal parathyroid hormone (PTH) level?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Parathyroid Hormone (PTH) Levels

The normal range for intact parathyroid hormone (PTH) in individuals with normal kidney function is 10-65 pg/mL (7.15 pmol/L). 1

Understanding PTH Reference Ranges

  • The normal PTH range of 10-65 pg/mL represents the standard reference range for individuals with normal kidney function 1, 2
  • When vitamin D status is taken into account (excluding subjects with low 25OHD levels), a narrower reference range of 10-46 pg/mL may be more appropriate 2
  • Most of the biological activity of PTH resides in the N-terminal portion, particularly in amino acid residues 1-7 1
  • PTH is an 84-amino acid molecule, and most current assays measure the "intact" PTH molecule 1

Factors Affecting PTH Levels

  • Vitamin D deficiency can lead to secondary hyperparathyroidism, as PTH levels rise to compensate for low vitamin D 1, 3
  • Serum calcium levels directly affect PTH secretion through the calcium-sensing receptor (CaR) in the parathyroid gland 1
  • Renal function significantly impacts PTH levels, with a moderate correlation between glomerular filtration rate and PTH (r = -0.36) 3
  • PTH levels correlate weakly with 25-hydroxyvitamin D levels (r = -0.15) 3

Clinical Implications of Normal vs. Abnormal PTH

  • PTH levels below normal (<10 pg/mL) may indicate hypoparathyroidism or vitamin D toxicity 2
  • Elevated PTH (>65 pg/mL) in patients with normal kidney function may suggest:
    • Primary hyperparathyroidism 4
    • Secondary hyperparathyroidism due to vitamin D deficiency 1, 3
    • Chronic kidney disease 1
  • In primary hyperparathyroidism, approximately 12% of surgically confirmed cases may have PTH levels within the normal range (≤46 pg/mL) 2

Special Considerations for Chronic Kidney Disease

  • In chronic kidney disease (CKD), PTH targets differ from the normal range due to skeletal resistance to PTH 5
  • For patients with CKD Stage 5 on dialysis, intact PTH should be maintained between 150-300 pg/mL (2-4 times the upper limit of normal) 6, 5
  • For CKD patients not on dialysis, PTH targets should progressively increase as kidney function declines 7, 6
  • Maintaining PTH levels too low in CKD patients can lead to adynamic bone disease, while levels too high can cause osteitis fibrosa 5, 8

Measurement Considerations

  • Many "intact PTH" assays also detect biologically inactive fragments (7-84 positions), which can lead to spurious elevations in CKD patients 1
  • PTH measurements should be interpreted as trends rather than isolated values due to assay variability 6
  • Different assays may have slightly different reference ranges, so laboratory-specific ranges should be considered 1

Clinical Pitfalls to Avoid

  • Attempting to maintain intact PTH levels of CKD patients in the "normal" range (<65 pg/mL) can lead to low bone formation and adynamic bone disease 1, 5
  • Relying solely on PTH without considering calcium, phosphorus, and vitamin D status can lead to suboptimal management 7, 6
  • Failing to recognize that normal PTH levels do not exclude primary hyperparathyroidism, as up to 12% of confirmed cases may have PTH within normal range 4, 2
  • Not accounting for vitamin D status when interpreting PTH levels can lead to misdiagnosis 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 1995

Guideline

Target PTH Level in CKD Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Target PTH Range for CKD Stages

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of hyperphosphatemia: the dangers of high PTH levels.

Pediatric nephrology (Berlin, Germany), 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.